In vitro, in vivo and in silico anti-hyperglycemic inhibition by sinigrin
Journal Title: Asian Pacific Journal of Tropical Medicine - Year 2017, Vol 10, Issue 4
Abstract
Objective: To evaluate the anti-hyperglycemic potential of sinigrin using in vitro, in silico and in vivo streptozotocin (STZ) induced hyperglycemic zebrafish model. Methods: The in vitro enzyme inhibition assay was carried out to determine the IC50 value against a-glucosidase and a-amylase, in silico molecular docking was performed against both enzymes with PyRx tool and simulations were performed using GROMACS tool. Hyperglycemia was induced in zebrafishes using three intraperitoneal injections on alternating days for 1 week at 350 mg/kg of STZ. Hyperglycemic fishes were treated intraperitoneally with 50, 100 and 150 mg of sinigrin/kg of body weight for 24 h and glucose levels were measured. Results: The sinigrin showed very strong inhibition against a-glucosidase and aamylase with 0.248 and 0.00124 mM while reference drug acarbose showed IC50 value of 73.0700 and 0.0017 mM against a-glucosidase and a-amylase, respectively. Kinetic analysis revealed that sinigrin has the mixed type mode of inhibition against a-glucosidase. Molecular docking results revealed its strong binding affinity with a-glucosidase (−10.00 kcal/mol) and a-amylase (−8.10 kcal/mol). Simulations graphs confirmed its stability against both enzymes. Furthermore, in hyperglycemic zebrafishes most significant (P < 0.001) reduction of glucose was occurred at 150 mg/kg, moderate significant reduction of glucose was observed at 100 mg/kg and no any significant reduction of glucose was measured at 50 mg/kg. Conclusions: It can be evident from the present results that sinigrin has potent antihyperglycemic activity and it may prove to be effective treatment for the hyperglycemia.
Authors and Affiliations
Sung-Yum Seo
Keywords
Related Articles
- EP ID EP267404
- DOI 10.1016/j.apjtm.2017.03.019
- Views 97
- Downloads 0
Identification and analysis of a processed cytochrome P450 pseudogene of the disease vector Aedes aegypti
Objective: To clone cytochrome P450 from Aedes aegypti (Ae. aegypti) and determine the characteristics using bioinformatics tools. Methods: Cytochrome P450 of Ae. aegypti was amplified using polymerase chain reaction, cl...
Melioidosis in India and Bangladesh: A review of case reports
Objective: To conduct an epidemiological and clinical review of published case reports of melioidosis from India and Bangladesh. Methods: Data from published case reports were abstracted and summarized. We further compar...
Clinical and environmental isolates of Burkholderia pseudomallei from Brazil: Genotyping and detection of virulence gene
Objective To evaluate the genetic diversity of clinical and environmental isolates of Burkholderia pseudomallei (B. pseudomallei) recovered in Ceará, Brazil, and screen these isolates for the presence of type three secr...
Efficacy of voriconazole on leishmaniasis by Leishmania major: An in vitro and in vivo study
Objective: To appraise the activity of voriconazole against Leishmania major (L. major) in vitro and its effectiveness on wound regeneration in cutaneous leishmaniasis in BALB/c mice. Methods: The IC50 of voriconazole ag...
Can miRNA712_3p be a promising biomarker for early diagnosis of toxoplasmosis?
Objective: To assess the role of miRNA712_3p as a specific biomarker in early detection of toxoplasmosis in plasma of mice acutely infected with Toxoplasma gondii. Methods: Real-time PCR was used to measure the level of...